Comparing Analgesic Regimen Effectiveness and Safety for Surgery (CARES) Trial - Trial NCT05722002
Access comprehensive clinical trial information for NCT05722002 through Pure Global AI's free database. This Phase 4 trial is sponsored by University of Michigan and is currently Recruiting. The study focuses on Surgery,Pain, Postoperative. Target enrollment is 900 participants.
This page provides complete trial specifications, intervention details, outcomes, and location information. Pure Global AI offers free access to ClinicalTrials.gov data, helping medical device and pharmaceutical companies navigate clinical research efficiently.
Study Focus
Sponsor & Location
University of Michigan
Timeline & Enrollment
Phase 4
Feb 06, 2023
Oct 01, 2024
Primary Outcome
Pain intensity based on Brief Pain Inventory (BPI) pain intensity score at the surgical site over 7 days post surgery,Safety outcome - number and severity of any adverse medication-related symptoms over 7 days post surgery
Summary
This trial is being completed to compare two commonly used options to treat pain after
 surgery. Participants that undergo gallbladder removal, hernia repair, and breast lump
 removal will be eligible to enroll. Eligible participants will be randomized to 1 of 2 groups
 of medications (Non-Steroidal Anti-Inflammatory Drugs (NSAIDS) plus acetaminophen or low dose
 opioids plus acetaminophen).
 
 It is anticipated that the NSAID group will have superior clinical outcomes and fewer side
 effects when compared to the opioid group.
ICD-10 Classifications
Data Source
ClinicalTrials.gov
NCT05722002
Non-Device Trial